The levels of anti-SARS-CoV-2 antibodies in plasma also did not correlate with poor disease outcome, suggesting that IgM, IgG antibodies specific for SARS-CoV-2 N antigen and B cells are not drivers of COVID-19 pathogenesis. This evidence concerns the gene CD40LG and COVID-19.